Position
Fidelity in Climb Bio, Inc.
Back to the book · All holders of CLYM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $39.6K$6.85 → $13.04
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.35K | $25.4K | — | — | — | 0.0% |
| Q1 2026 | 6.4K | $43.8K | $6.85 | $18.1K | $329 | 0.0% |
| Q2 2026 | 6.79M | $88.5M | $13.04 | $39.6K | $88.5M | 0.0% |